Table 5.

Levels of hs-CRP, TNF-α, IL-1β and MMP-9

Group	Control group (n=59)	Experimental group (n=59)	t	P
hs-CRP (μg/mL)
Before treatment	11.04±2.56	11.22±2.03	0.423	0.673
After treatment	8.36±1.44###	6.25±1.13###,***	8.854	<0.001
t	7.009	16.430
P	<0.001	<0.001
TNF-α (pg/mL)
Before treatment	15.26±5.11	16.07±4.82	0.886	0.378
After treatment	12.30±3.25##	10.31±2.05###,**	3.978	0.001
t	3.754	8.447
P	0.001	<0.001
IL-1β (pg/mL)
Before treatment	1.60±0.24	1.57±0.30	0.560	0.550
After treatment	1.36±0.18###	1.06±0.20###,***	8.564	<0.001
t	6.145	10.860
P	<0.001	<0.001
MMP-9 (μg/mL)
Before treatment	46.80±6.60	47.15±5.99	0.302	0.763
After treatment	35.17±4.66###	26.16±4.22###,***	11.010	<0.001
t	11.060	22.000
P	<0.001	<0.001

Note: Compared with before treatment;

^##P<0.01;

^###P<0.001.

Compared with the control group;

^**P<0.01;

^***P<0.001.

hs-CRP: high-sensitivity C-reactive protein. TNF-α: tumor necrosis factor-α; IL-1β: interleukin-1β; MMP-9: matrix metalloproteinase-9.